Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
State Street Corporation and its affiliate SSGA Funds Management, Inc. report significant beneficial ownership of Sarepta Therapeutics common stock. State Street and related entities report beneficial ownership of 8,916,103 shares, representing 8.4% of the common stock, with 8,642,126 shares having shared voting power and all 8,916,103 shares having shared dispositive power and no sole voting or dispositive power.
Separately, SSGA Funds Management, Inc. reports beneficial ownership of 6,285,547 shares, or 6% of the class, with shared voting power over 6,271,147 shares and shared dispositive power over 6,285,547 shares. The securities are held through various State Street investment adviser and bank subsidiaries identified in the filing.
Key Figures
State Street beneficial ownership:8,916,103 sharesState Street percent of class:8.4 %State Street shared voting power:8,642,126 shares+5 more
8 metrics
State Street beneficial ownership8,916,103 sharesBeneficially owned Sarepta Therapeutics common stock; percent of class 8.4%
State Street percent of class8.4 %Percent of Sarepta Therapeutics common stock class beneficially owned by State Street entities
State Street shared voting power8,642,126 sharesShares of Sarepta common stock with shared voting power reported by State Street
State Street shared dispositive power8,916,103 sharesShares of Sarepta common stock with shared dispositive power reported by State Street
SSGA FM beneficial ownership6,285,547 sharesBeneficially owned Sarepta common stock reported separately by SSGA Funds Management, Inc.
SSGA FM percent of class6 %Percent of Sarepta common stock class beneficially owned by SSGA Funds Management, Inc.
SSGA FM shared voting power6,271,147 sharesShares of Sarepta common stock with shared voting power reported by SSGA Funds Management, Inc.
SSGA FM shared dispositive power6,285,547 sharesShares of Sarepta common stock with shared dispositive power reported by SSGA Funds Management, Inc.
Beneficially owned describes securities or assets where a person has the economic rights and control—such as the right to receive dividends and to direct voting—even if legal title is held in another name. Think of it like having the keys and using a car that’s registered to someone else: you get the benefits and make decisions. Investors care because beneficial ownership reveals who truly controls value and voting power, affecting corporate decisions and takeover dynamics.
shared voting powerfinancial
"Shared Voting Power 8,642,126.00"
Shared voting power occurs when two or more parties jointly have the right to vote or decide how a block of company shares is cast, like co-owners who must agree before moving a piece of furniture. Investors care because who controls voting rights affects board elections, major corporate decisions and takeover outcomes, and shared control can alter regulatory disclosures and the practical influence any holder has over a company’s direction and value.
shared dispositive powerfinancial
"Shared Dispositive Power 8,916,103.00"
Schedule 13Gregulatory
"form_type": "SCHEDULE 13G""
A Schedule 13G is a formal document that investors file with the government when they acquire a large ownership stake in a company, usually for investment purposes rather than control. It helps keep the public informed about who owns significant parts of a company's shares, which can influence how the company is managed and how investors make decisions. Filing this schedule is important for transparency and understanding the ownership landscape of publicly traded companies.
percent of classfinancial
"Percent of class: 8.4 %"
Percent of class is the portion of a specific category of securities—such as a company’s common shares, preferred shares, or a bond series—that takes part in or approves a corporate action (vote, consent, tender, etc.). Investors watch this number because it reveals how much support or opposition exists within that particular shareholder group; like counting how many members of a club back a proposal, it can determine whether a plan passes or how influence is distributed.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
How much of Sarepta Therapeutics (SRPT) does State Street Corporation beneficially own?
State Street Corporation and related entities report 8,916,103 Sarepta Therapeutics common shares, representing 8.4% of the class. They have shared voting power over 8,642,126 shares and shared dispositive power over all 8,916,103 shares.
What is SSGA Funds Management, Inc.’s ownership stake in Sarepta Therapeutics (SRPT)?
SSGA Funds Management, Inc. reports beneficial ownership of 6,285,547 shares of Sarepta Therapeutics common stock, or 6% of the class, with shared voting power over 6,271,147 shares and shared dispositive power over 6,285,547 shares.
Does State Street have sole voting or dispositive power over Sarepta Therapeutics (SRPT) shares?
State Street reports 0 shares with sole voting power and 0 shares with sole dispositive power. It reports shared voting power over 8,642,126 shares and shared dispositive power over 8,916,103 shares of Sarepta Therapeutics common stock.
Which subsidiaries hold Sarepta Therapeutics (SRPT) shares for State Street?
The shares are associated with several subsidiaries, including SSGA Funds Management, Inc., State Street Bank and Trust Company, State Street Global Advisors Europe Limited, State Street Global Advisors Limited, State Street Global Advisors Trust Company, and State Street Global Advisors, Ltd..
Who signed the Schedule 13G for State Street’s holdings in Sarepta Therapeutics (SRPT)?
The filing is signed by Elizabeth Schaefer, Senior Vice President and Chief Accounting Officer, and Brian Harris, Chief Compliance Officer, each signing on 08/07/2026 on behalf of the reporting persons.
Is there any group or other person with over 5% interest disclosed for Sarepta Therapeutics (SRPT)?
The filing states “NOT APPLICABLE” for both ownership of more than 5 percent on behalf of another person and identification of members of a group, indicating no such additional parties are identified in these items.
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 13G
UNDER THE SECURITIES EXCHANGE ACT OF 1934
SAREPTA THERAPEUTICS INC
(Name of Issuer)
COMMON STOCK
(Title of Class of Securities)
803607100
(CUSIP Number)
06/30/2026
(Date of Event Which Requires Filing of this Statement)
Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)
schemaVersion:
SCHEDULE 13G
CUSIP Number(s):
803607100
1
Names of Reporting Persons
STATE STREET CORPORATION
2
Check the appropriate box if a member of a Group (see instructions)
(a)
(b)
3
Sec Use Only
4
Citizenship or Place of Organization
MASSACHUSETTS
Number of Shares Beneficially Owned by Each Reporting Person With:
5
Sole Voting Power
0.00
6
Shared Voting Power
8,642,126.00
7
Sole Dispositive Power
0.00
8
Shared Dispositive Power
8,916,103.00
9
Aggregate Amount Beneficially Owned by Each Reporting Person
8,916,103.00
10
Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)
11
Percent of class represented by amount in row (9)
8.4 %
12
Type of Reporting Person (See Instructions)
HC
SCHEDULE 13G
CUSIP Number(s):
803607100
1
Names of Reporting Persons
SSGA FUNDS MANAGEMENT, INC.
2
Check the appropriate box if a member of a Group (see instructions)
(a)
(b)
3
Sec Use Only
4
Citizenship or Place of Organization
MASSACHUSETTS
Number of Shares Beneficially Owned by Each Reporting Person With:
5
Sole Voting Power
0.00
6
Shared Voting Power
6,271,147.00
7
Sole Dispositive Power
0.00
8
Shared Dispositive Power
6,285,547.00
9
Aggregate Amount Beneficially Owned by Each Reporting Person
6,285,547.00
10
Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)
11
Percent of class represented by amount in row (9)
6 %
12
Type of Reporting Person (See Instructions)
IA
SCHEDULE 13G
Item 1.
(a)
Name of issuer:
SAREPTA THERAPEUTICS INC
(b)
Address of issuer's principal executive offices:
215 FIRST STREET SUITE 415, CAMBRIDGE, MASSACHUSETTS, 02142
Item 2.
(a)
Name of person filing:
SSGA FUNDS MANAGEMENT, INC.;STATE STREET CORPORATION;
(b)
Address or principal business office or, if none, residence:
1 CONGRESS STREET, SUITE 1, BOSTON MA 02114, UNITED STATES (FOR ALL REPORTING PERSONS)
(c)
Citizenship:
MA
(d)
Title of class of securities:
COMMON STOCK
(e)
CUSIP Number(s):
803607100
Item 3.
If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
(a)
Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);
(b)
Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);
(c)
Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);
(d)
Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);
(e)
An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);
(f)
An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);
(g)
A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);
(h)
A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
(i)
A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
(j)
A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J). If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J),
please specify the type of institution:
(k)
Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K).
Item 4.
Ownership
(a)
Amount beneficially owned:
8916103.00
(b)
Percent of class:
8.4 %
(c)
Number of shares as to which the person has:
(i) Sole power to vote or to direct the vote:
0
(ii) Shared power to vote or to direct the vote:
8,642,126
(iii) Sole power to dispose or to direct the disposition of:
0
(iv) Shared power to dispose or to direct the disposition of:
8,916,103
Item 5.
Ownership of 5 Percent or Less of a Class.
Not Applicable
Item 6.
Ownership of more than 5 Percent on Behalf of Another Person.
If any other person is known to have the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, such securities, a statement to that effect should be included in response to this item and, if such interest relates to more than 5 percent of the class, such person should be identified. A listing of the shareholders of an investment company registered under the Investment Company Act of 1940 or the beneficiaries of employee benefit plan, pension fund or endowment fund is not required.
NOT APPLICABLE
Item 7.
Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.
If a parent holding company has filed this schedule, pursuant to Rule 13d-1(b)(ii)(G), so indicate under Item 3(g) and attach an exhibit stating the identity and the Item 3 classification of the relevant subsidiary. If a parent holding company has filed this schedule pursuant to Rule 13d-1(c) or Rule 13d-1(d), attach an exhibit stating the identification of the relevant subsidiary.
SSGA FUNDS MANAGEMENT, INC. (IA);STATE STREET BANK AND TRUST COMPANY (BK);STATE STREET GLOBAL ADVISORS EUROPE LIMITED (IA);STATE STREET GLOBAL ADVISORS LIMITED (IA);STATE STREET GLOBAL ADVISORS TRUST COMPANY (IA);STATE STREET GLOBAL ADVISORS, LTD. (IA);
Item 8.
Identification and Classification of Members of the Group.
If a group has filed this schedule pursuant to §240.13d-1(b)(1)(ii)(K), so indicate under Item 3(k) and attach an exhibit stating the identity and Item 3 classification of each member of the group. If a group has filed this schedule pursuant to §240.13d-1(c) or §240.13d-1(d), attach an exhibit stating the identity of each member of the group.
NOT APPLICABLE
Item 9.
Notice of Dissolution of Group.
Notice of dissolution of a group may be furnished as an exhibit stating the date of the dissolution and that all further filings with respect to transactions in the security reported on will be filed, if required, by members of the group, in their individual capacity. See Item 5.
NOT APPLICABLE
Item 10.
Certifications:
By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under § 240.14a-11.
SIGNATURE
After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.
